Literature DB >> 12532038

Candidate gene polymorphisms among North Indians and their association with schizophrenia in a case-control study.

Prachi Semwal1, Suman Prasad, Panchami G Varma, A M Bhagwat, S N Deshpande, B K Thelma.   

Abstract

Knowledge of candidate gene polymorphisms in a population is useful for a variety of gene-disease association studies, particularly for some complex traits. A number of candidate genes, a majority of them from the monoaminergic pathway in the brain, have been very popular in association studies with schizophrenia, a neuropsychiatric disorder. In this study diallelic/multiallelic polymorphisms in some dopaminergic, serotonergic and membrane-phospholipid-related genes have been evaluated in a control population recruited from North India. Association, if any, of these allelic variants with schizophrenia has been tested using a case-control approach. The case data have been taken from our published family-based association studies in schizophrenia. Of the eight genes tested in this study, association with schizophrenia was observed for only two gene polymorphisms, one in the promoter region of the serotonin 2A receptor gene and the other in the tryptophan hydroxylase gene. One new allele for the dopamine transporter gene (with eight repeats, 570-bp size), not reported in any population so far, has been identified in one individual in our sample. The data generated in this study, besides providing a normative background for various disease association studies, are a significant contribution to the population-specific genome database, a currently growing requirement.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12532038     DOI: 10.1007/BF02715902

Source DB:  PubMed          Journal:  J Genet        ISSN: 0022-1333            Impact factor:   1.166


  37 in total

1.  Genetic mapping of the human tryptophan hydroxylase gene on chromosome 11, using an intronic conformational polymorphism.

Authors:  D A Nielsen; M Dean; D Goldman
Journal:  Am J Hum Genet       Date:  1992-12       Impact factor: 11.025

2.  An MspI polymorphism in the hyman serotonin receptor gene (HTR2): detection by DGGE and RFLP analysis.

Authors:  J T Warren; M L Peacock; L C Rodriguez; J K Fink
Journal:  Hum Mol Genet       Date:  1993-03       Impact factor: 6.150

3.  Serotonin and schizophrenia.

Authors:  C A Tamminga
Journal:  Biol Psychiatry       Date:  1998-12-01       Impact factor: 13.382

Review 4.  Antipsychotic drug actions: a clue to the neuropathology of schizophrenia?

Authors:  S Matthysse
Journal:  Fed Proc       Date:  1973-02

5.  Further studies on tryptophan hydroxylase in rat brainstem and beef pineal.

Authors:  E Jequier; D S Robinson; W Lovenberg; A Sjoerdsma
Journal:  Biochem Pharmacol       Date:  1969-05       Impact factor: 5.858

6.  Increased serum phospholipase A2 activity in schizophrenia: a replication study.

Authors:  W F Gattaz; C V Hübner; T J Nevalainen; T Thuren; P K Kinnunen
Journal:  Biol Psychiatry       Date:  1990-09-15       Impact factor: 13.382

7.  Schizophrenia, chronic hospitalization and the 5-HT2C receptor gene.

Authors:  R H Segman; R P Ebstein; U Heresco-Levy; M Gorfine; M Avnon; E Gur; L Nemanov; B Lerer
Journal:  Psychiatr Genet       Date:  1997       Impact factor: 2.458

8.  Increased platelet phospholipase A2 activity in schizophrenia.

Authors:  W F Gattaz; A Schmitt; A Maras
Journal:  Schizophr Res       Date:  1995-07       Impact factor: 4.939

9.  Increased plasma phospholipase-A2 activity in schizophrenic patients: reduction after neuroleptic therapy.

Authors:  W F Gattaz; M Köllisch; T Thuren; J A Virtanen; P K Kinnunen
Journal:  Biol Psychiatry       Date:  1987-04       Impact factor: 13.382

Review 10.  The membrane hypothesis of schizophrenia.

Authors:  D F Horrobin; A I Glen; K Vaddadi
Journal:  Schizophr Res       Date:  1994-10       Impact factor: 4.939

View more
  8 in total

1.  A Meta-analysis of the Association Between SLC6A3 Gene Polymorphisms and Schizophrenia.

Authors:  Feng-Ling Xu; Mei Ding; Xue Wu; Yong-Ping Liu; Xi Xia; Jun Yao; Bao-Jie Wang
Journal:  J Mol Neurosci       Date:  2019-08-22       Impact factor: 3.444

Review 2.  Genetics of schizophrenia from a clinicial perspective.

Authors:  Prachi Kukshal; B K Thelma; Vishwajit L Nimgaonkar; Smita N Deshpande
Journal:  Int Rev Psychiatry       Date:  2012-10

Review 3.  Meta-analysis shows association between the tryptophan hydroxylase (TPH) gene and schizophrenia.

Authors:  Dawei Li; Lin He
Journal:  Hum Genet       Date:  2006-06-02       Impact factor: 4.132

4.  Enhancing genotyping of MAOA-LPR and 5-HTT-LPR in rhesus macaques (Macaca mulatta).

Authors:  Genesio M Karere; Erin Sullivan; Erin L Kinnally; John P Capitanio; Leslie A Lyons
Journal:  J Med Primatol       Date:  2012-10-18       Impact factor: 0.667

Review 5.  The Role of a Catechol-O-Methyltransferase (COMT) Val158Met Genetic Polymorphism in Schizophrenia: A Systematic Review and Updated Meta-analysis on 32,816 Subjects.

Authors:  Thelma Beatriz González-Castro; Yazmin Hernández-Díaz; Isela Esther Juárez-Rojop; María Lilia López-Narváez; Carlos Alfonso Tovilla-Zárate; Ana Fresan
Journal:  Neuromolecular Med       Date:  2016-03-28       Impact factor: 3.843

6.  Molecular biology research in neuropsychiatry: India's contribution.

Authors:  T S Sathyanarayana Rao; B N Ramesh; P Vasudevaraju; K S J Rao
Journal:  Indian J Psychiatry       Date:  2010-01       Impact factor: 1.759

Review 7.  Distribution of genetic polymorphisms of genes encoding drug metabolizing enzymes & drug transporters - a review with Indian perspective.

Authors:  Gurusamy Umamaheswaran; Dhakchinamoorthi Krishna Kumar; Chandrasekaran Adithan
Journal:  Indian J Med Res       Date:  2014-01       Impact factor: 2.375

Review 8.  Theranostic Biomarkers for Schizophrenia.

Authors:  Matea Nikolac Perkovic; Gordana Nedic Erjavec; Dubravka Svob Strac; Suzana Uzun; Oliver Kozumplik; Nela Pivac
Journal:  Int J Mol Sci       Date:  2017-03-30       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.